Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-021120

Director sold 51,343 shares at an average $10.34 ($530,811)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-05-25 Sale : show line 1 in the form −11,456 $10.02 $114,789 4,551,359 I
2016-05-26 Sale : show line 2 in the form −39,887 $10.43 $416,021 4,511,472 I
Open-market sales · 51,343 sh · avg $10.34 · $530,811
Loading xslF345X03/doc4.xml…